Tsu, Japan

Yasuo Chinzei

This inventor holds 2 USPTO granted patents. Top assignee: Mie University. Active years: 2005-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuo Chinzei. Retrieved from https://idiyas.com/inventor/yasuo-chinzei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Yasuo Chinzei

Introduction

Yasuo Chinzei is a notable inventor based in Tsu, Japan. He has made significant contributions to the field of medical science, particularly in the development of proteins that inhibit platelet aggregation. His work has the potential to impact treatments for serious cardiovascular conditions.

Latest Patents

Yasuo Chinzei holds 2 patents related to his research. His latest patents include the Ti-4 protein derived from Triatoma infestans, which exhibits activity to inhibit platelet aggregation. This invention provides the Ti-4 protein, obtained from the salivary gland, and the Ti-4 gene encoding the protein. The Ti-4 protein shows inhibitory activity on platelet aggregation, making it a promising candidate for a medicine that could prevent and treat myocardial infarction, pulmonary infarction, and cerebral infarction. Additionally, the Ti-3 protein, also derived from Triatoma infestans, has similar properties and applications, serving as a lead compound in the development of novel platelet aggregation inhibitors.

Career Highlights

Yasuo Chinzei is affiliated with Mie University, where he conducts his research and development work. His innovative contributions to the field of medicine have garnered attention and recognition.

Collaborations

He collaborates with notable colleagues, including Masao Yuda and Yuki Orito, who contribute to his research endeavors.

Conclusion

Yasuo Chinzei's work in developing proteins that inhibit platelet aggregation represents a significant advancement in medical science. His patents and research have the potential to lead to new treatments for critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…